Common use of Development Efforts Clause in Contracts

Development Efforts. ▇▇▇▇▇▇▇ shall use commercially reasonable efforts to carry out development of the Initial Product in accordance with the Development Plan, and the Additional Products, if any, in accordance with the Additional Product Development Plan. If ▇▇▇▇▇▇▇ determines that it will be unable to accomplish any of the key clinical events identified in the relevant Development Plan within 6 months of the date specified in such Development Plan, it shall promptly notify the Development Committee, and it shall develop a revised Development Plan for the relevant Licensed Product. This revised plan shall set new Critical Target Dates. As per Section 3.1, ▇▇▇▇▇▇▇ shall have the final decision making authority with respect to all aspects of any revised Development Plan, except that DTI must agree to any change in the Critical Target Dates, such agreement not to be unreasonably withheld. In the event DTI does not agree to the Critical Target Dates set forth in the revised plan, then the most recently approved Critical Target Dates shall apply and ▇▇▇▇▇▇▇ may, at its election, proceed under Section 3.5(c).

Appears in 3 contracts

Sources: Exclusive License Agreement (Aderis Pharmaceuticals Inc), Exclusive License Agreement (Aderis Pharmaceuticals Inc), Exclusive License Agreement (Aderis Pharmaceuticals Inc)